Abstract
Although a biochemical abnormality has been postulated in the etiology of schizophrenia, evidence supporting this hypothesis has been conflicting. Because of the presence of somatostatin-like immunoreactivity (SLI) in limbic system nuclei of the brain, we examined postmortem concentrations of SLI in patients dying with schizophrenia and in normal controls. Concentrations of SLI in Brodmann cortical area 38, hippocampus, caudate, putamen, nucleus accumbens, and both segments of the globus pallidus were not significantly different from controls. In addition, we examined both SLI and neuropeptide-Y-like immunoreactivity (NPYLI) in subnuclei of the amygdala and the substantia innominata. There were no significant alterations in either neuropeptide as compared with controls.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adrian T. E., Allen J. M., Bloom S. R., Ghatei M. A., Rossor M. N., Roberts G. W., Crow T. J., Tatemoto K., and Polak J. M. (1983) Neuropeptide Y distribution in human brain.Nature 306, 584–586.
Allen Y. S., Adrian T. E., Allen J. M., Tatemoto K., Crow T. J., Bloom S. R., and Polak J. M. (1983) Neuropeptide Y distribution in the rat brain.Science 221, 877–879.
Arnold M. A., Reppert S. M., Rorstad O. P., Sagar S. M., Keutmann H. T., Perlow M. J., and Martin J. B. (1982) Temporal patterns of somatostatin immunoreactivity in the cerebrospinal fluid of the rhesus monkey: Effect of environmental lighting.J. Neurosci. 2, 574–580.
Beal M. F. and Martin J. B. (1984a) The effect of somatostatin on striatal catecholamines.Neurosci. Lett. 44, 271–276.
Beal M. F. and Martin J. B. (1984b) Effects of neuroleptic drugs on brain somatostatin-like immunoreactivity.Neurosci. Lett. 47, 125–130.
Beal M. F., Chattha G. K., and Martin J. B. (1986a) A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain.Brain Res. 377, 240–245.
Beal M. F., Mazurek M. F., Lorenz L. J., Chattha G. K., Ellison D. W., and Martin J. B. (1986b) An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions.Neurosci. Lett. 64, 69–74.
Beal M. F., Mazurek M. F., and Martin J. B. (1986c) A comparison of somatostatin and neuropeptide Y distribution in monkey brain.Brain Res., in press.
Bird E. D. and Iversen L. L. (1974) Huntington's chorea: Postmortem measurement of glutamic acid decarboxylase, choline acetyltransferase, and dopamine in basal ganglia.Brain. 97, 457–472.
Bird E. D., Spokes E. G. S., and Iversen L. L. (1979) Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia.Brain. 102, 347–360.
Bohlen P., Stein S., Dairman W., and Udenfriend S. (1973) Fluorometric assay of proteins in the nanogram range.Arch. Biochem. Biophys. 155, 213–220.
Cooper P. E., Fernstrom M. H., Rorstad O. P., Leeman S. E., and Martin J. B. (1981) The regional distribution of somatostatin, substance P, and neurotensin in human brain.Brain Res. 218, 219–232.
Dawbarn D., Hunt S. P., and Emson P. C. (1984) Neuropeptide Y: Regional distribution chromatographic characterization and immunohistochemical demonstration in post-mortem human brain.Brain Res. 296, 168–173.
Epelbaum J., Tapia-Arancibia L., Kordon C., Ottesen O. P., and Ben-Ari Y. (1979) Regional distribution of somatostatin within the amygdaloid complex of the rat brain.Brain Res. 174, 172–174.
Everitt B. J., Hokfelt T., Terenius L., Tatemoto K., Mutt V., and Goldstein M. (1984) Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity in the central nervous system of the rat.Neuroscience 11, 443–462.
Feighner J. P., Robins E., Guzes S. P., Woodruff R. A., Winokur E., and Munoz R. J. (1972) Diagnostic criteria for use in psychiatric research.Arch. Gen. Psych. 26, 57–63.
Ferrier I. W., Roberts G. W., Crow T. J., Johnstone E. C., Owens D. G. C., Lee Y. C., O'Shaughenssey D., Adrian T. E., Polak J. M., and Bloom S. R. (1983) Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia.Life Sci. 33, 475–482.
Farley I. J., Price K. S., McCullough E., Deck J. H. N., Hordyhski W., and Hornykiewicz O. (1978) Norepinephrine in chronic paranoid schizophrenia: Abnormal levels in limbic forebrain.Science 200, 456–458.
Finely J. C. W., Maderdrut J. L., Rogers, L. J., and Petrusz P. (1981) The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system.Neuroscience 6, 2173–2192.
Hokfelt T., Lundberg J. M., Lagercrantz H., Tatemoto K., Mutt V., Lindberg J., Terenius L., Everitt B. J., Fuxe K., Agnati L., and Goldstein M. (1983) Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata.Neurosci. Lett. 36, 217–222.
Kety S. S., Rosenthal D., Wender P. H., Schulsinger F., and Jacobsen B. (1975) Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: A preliminary report based on psychiatric interviews, inGenetic Research in Psychiatry (Fieve R., Rosenthal R., and Brill H., eds.) pp. 147–165. Johns Hopkins, Baltimore, MD.
Kluver H. and Bucy P. C. (1939) Preliminary analysis of functions of the temporal lobes in monkeys.Arch. Neurol. Psych. 42, 979–1000.
Lilly R., Cummings J. L., Benson D. F., and Frankel M. (1983) The human Kluver-Bucy syndrome.Neurology 33, 1141–1145.
Murray E. A. and Mishkin M. (1985) Amygdalectomy impairs cross modal association in monkeys.Science 228, 604–606.
Nemeroff C. B., Youngblood W. W., Manberg P. J., Prange A. J., and Kizer J. S. (1983) Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.Science 221, 972–975.
Reynolds G. P. (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia.Nature 305, 527–529.
Roberts G. W., Ferrier I. N., Lee Y., Crow T. J., Johnstone E. C., Owens D. G. C., Bacarese-Hamilton A. J., McGregor G., O'Shaughnessey D., Polak J. M., and Bloom S. R. (1983) Peptides, the limbic lobe and schizophrenia.Brain Res. 288, 199–211.
Roberts G. W., Woodhams P. L., Polak J. M., and Crow T. J. (1982) Distribution of neuropeptides in the limbic system of the rat: The amygdaloid complex.Neuroscience 7, 99–131.
Svendsen C. N. and Bird E. D. (1985) Acetylcholinesterase staining of the human amygdala.Neurosci. Lett. 59, 313–318.
Svendsen C. N., Langlais P. J., Benes F. M., and Bird E. D. (1986) Monoamine levels in the left and right amygdaloid complex of schizophrenic postmortem brain tissue, inBiological Psychiatry (Shagass C. et al., eds.) pp. 1115–1117, Elsevier, Amsterdam, Netherlands.
Walsh F. X., Stevens T. J., Langlais P. J., and Bird E. D. (1982) Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.Ann. Neurol. 12, 52–55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beal, M.F., Svendsen, C.N., Bird, E.D. et al. Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia. Neurochemical Pathology 6, 169–176 (1987). https://doi.org/10.1007/BF02834198
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02834198